机构:[1]Capital Med Univ, Beijing Tongren Hosp, Dept Anesthesiol, Beijing, Peoples R China医技科室麻醉科首都医科大学附属北京同仁医院首都医科大学附属同仁医院[2]Capital Med Univ, Beijing Shijitan Hosp, Biomed Innovat Ctr, Beijing, Peoples R China[3]Capital Med Univ, Beijing Shijitan Hosp, Beijing Key Lab Therapeut Canc Vaccines, Beijing, Peoples R China[4]China Acad Chinese Med Sci, Inst Basic Theory Chinese Med, Beijing, Peoples R China[5]Capital Med Univ, Beijing Shijitan Hosp, Dept Anesthesiol, Beijing, Peoples R China
Tetrahydroxy stilbene glycoside (TSG), which is the primary active substance of Chinese herbal medicine called Polygonum multiflorum, has been acknowledged to alleviate Alzheimer's disease (AD)-induced learning disorder in the transgene mice. Because the microglia activation is really important during the AD progression, herein, we determined the effects of TSG on AD neuropathology, microglia polarization and its underlying mechanism. We used APP/PS1 mice along with immunohistochemistry and immunofluorescence techniques to evaluate the function of TSG as 60, 120 and 180 mg/kg on A beta deposition, neuronal loss and microglia polarization induced by AD. Additionally, we assessed the effects of TSG on TREM2 signalling using both molecular docking and Western blot analysis. TSG was found to promote neuronal survival and decrease A beta deposition in APP/PS1 mice. Moreover, TSG reduced microglia M1 polarization and modulated the TREM2/PI3K/AKT signalling pathways. TSG could reduce neuronal impairment by mediating the microglia polarization by TREM2/PI3K/AKT signalling pathway in APP/PS1 mice and is a latent pharmacological research direction for the therapy in the patients with AD.
基金:
This work was supported by the National Natural Science Foundation of China (No. 82271206, 82204645) and the Fund of Beijing Shijitan
Hospital, Capital Medical University (2022-C02).